ESR2 and breast carcinoma: While this conclusion is consistent with reports that breast cancer survival was not influenced by ERβ expression in patients with ERα+ or ERα-negative (ER−) tumors [8, 9], other investigators found a direct correlation between ERβ-positivity and overall survival [10].